E

Estrella Immunopharma Inc
NASDAQ:ESLA

Watchlist Manager
Estrella Immunopharma Inc
NASDAQ:ESLA
Watchlist
Price: 1.05 USD 0.96% Market Closed
Market Cap: $44.1m

Profitability Summary

Estrella Immunopharma Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Estrella Immunopharma Inc

Margins Comparison
Estrella Immunopharma Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Estrella Immunopharma Inc
NASDAQ:ESLA
44.1m USD
Loading...
Loading...
US
GE Vernova LLC
NYSE:GEV
230B USD
Loading...
Loading...
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR
Loading...
Loading...
US
China Industrial Group Inc
OTC:CIND
121B USD
Loading...
Loading...
NL
Nepi Rockcastle NV
JSE:NRP
97.4B ZAR
Loading...
Loading...
US
Schlumberger NV
NYSE:SLB
80B USD
Loading...
Loading...
US
Baker Hughes Co
NASDAQ:BKR
62.4B USD
Loading...
Loading...
CH
Galderma Group AG
SIX:GALD
35.5B CHF
Loading...
Loading...
US
Inspire Veterinary Partners Inc
NASDAQ:IVP
38.9B USD
Loading...
Loading...
US
CoreWeave Inc
NASDAQ:CRWV
37.6B USD
Loading...
Loading...
US
Halliburton Co
NYSE:HAL
33.8B USD
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Estrella Immunopharma Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Estrella Immunopharma Inc
NASDAQ:ESLA
44.1m USD
Loading...
Loading...
Loading...
Loading...
US
GE Vernova LLC
NYSE:GEV
230B USD
Loading...
Loading...
Loading...
Loading...
UK
Eight Capital Partners PLC
F:ECS
158.4B EUR
Loading...
Loading...
Loading...
Loading...
US
China Industrial Group Inc
OTC:CIND
121B USD
Loading...
Loading...
Loading...
Loading...
NL
Nepi Rockcastle NV
JSE:NRP
97.4B ZAR
Loading...
Loading...
Loading...
Loading...
US
Schlumberger NV
NYSE:SLB
80B USD
Loading...
Loading...
Loading...
Loading...
US
Baker Hughes Co
NASDAQ:BKR
62.4B USD
Loading...
Loading...
Loading...
Loading...
CH
Galderma Group AG
SIX:GALD
35.5B CHF
Loading...
Loading...
Loading...
Loading...
US
Inspire Veterinary Partners Inc
NASDAQ:IVP
38.9B USD
Loading...
Loading...
Loading...
Loading...
US
CoreWeave Inc
NASDAQ:CRWV
37.6B USD
Loading...
Loading...
Loading...
Loading...
US
Halliburton Co
NYSE:HAL
33.8B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Estrella Immunopharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett